Acurx Pharmaceuticals (ACXP) - Price Projection - August 19th, 2024

(22:19)

BioPub Presents Acurx Pharmaceuticals May 18, 2024

(1:12:6)

Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) David Luci, President/CEO.

(6:57)

Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s interview with David Luci, President/CEO

(10:13)

The latest news from ACURX Pharma on New to the Street

(47)

Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.

(8:23)

Duel Impact Antibiotics - Acurx Pharmaceuticals with David Luci

(11:1econd)

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP)

(28:3)

The Problem with Current Antibiotics - David Luci, CEO of Acurx Pharmaceuticals

(11:1econd)

David Luci, President/CEO of Acurx Pharmaceuticals discusses the new class of antibotics.

(8:21)

Acurx Pharmaceuticals (NASDAQ: ACXP)

(30:33)

Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s interview with David Luci, President/CEO.

(5:37)

A New Class of Antibiotics - Acurx Pharmaceuticals - David Luci

(9:1econd)

Biopharmaceutical – Acurx Pharmaceuticals, Inc.'s interview with David Luci, President/CEO

(4:31)

Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.

(10:22)

Biopharmaceutical – Acurx Pharmaceuticals, Inc.'s interview with David Luci, President/CEO.

(6:27)

Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President / CEO.

(10:57)

Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.

(6:37)

David Luci, President/CEO of Acurx Pharmaceuticals talks about the need for new antibiotics.

(9:1econd)